SAN ANTONIO – They risk their lives for us in more ways than one. In 2018, KSAT began reporting on the firefighter-cancer connection. In the seven years since, there have been extensive changes to ...

WASHINGTON--(BUSINESS WIRE)--The College of American Pathologists (CAP) has renewed its partnership with the International Agency for Research on Cancer (IARC), to continue collaborating on Cancer ...

NORTHFIELD, Ill.--(BUSINESS WIRE)--The College of American Pathologists (CAP) released updates to the CAP Cancer Protocols, clinical guidance for reporting pathologic features in the treatment of ...

The FDA approved protocol updates to a tasquinimod trial in myelofibrosis, allowing broader enrollment and combination use ...

Fifty-four-year-old Albert Khoury is six months post lung transplant. His surgery is uncommon. Doctors diagnosed him with stage four lung cancer at the start of the pandemic. Northwestern Medicine in ...

Shaka Hislop says it is "alarming" that tests for prostate cancer are not "regular and "standardised" in the United Kingdom.

Over the past 50 years, multiple pathology organizations worldwide have evolved in cancer histopathology reporting from subjective, narrative assessments to structured, synoptic formats using ...

The CAP Cancer Protocols contain guidance and standardized clinical content that support best practices in cancer patient care. The CAP electronic Cancer Checklists (eCCs) allow for that content to be ...

Christine Amoroso, B.S.N., RN, OCN, figured out the best way to deliver direct-to-kidney treatment for her patients. Chris has been a proud Fox Chase Cancer Center nurse since May 1987. Currently, ...

Scientists at Fred Hutchinson Cancer Research Center are working towards a less invasive, more informative biopsy technique as well as a more precise protocol to identify potential treatments for ...

A non-NIH clinical trial is now testing ivermectin, the antiparasitic drug that became a lightning rod during the COVID-19 pandemic, as a potential weapon against one of the most aggressive forms of ...

Anixa Biosciences, Inc. ANIX on Monday provided an update on patient outcomes observed in its ongoing Phase 1 ovarian cancer ...